Increasing the value of radiotherapy in breast cancer
- PMID: 33845036
- DOI: 10.1016/S1470-2045(21)00120-0
Increasing the value of radiotherapy in breast cancer
Conflict of interest statement
I report serving on the Board of Directors for Empyrean Medical Systems, outside the submitted work; and a patent, UTSC.P1296US.C1, Apparatus and Methods for Magnetic Control of Electron Beams, issued to The University of Texas MD Anderson Cancer Center, licensed to Empyrean Medical Systems.
Comment on
-
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.Lancet Oncol. 2021 May;22(5):597-608. doi: 10.1016/S1470-2045(21)00080-2. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845035 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources